MedTrace Logo

High Dose Cholecalciferol to Reduce the Incidence of Gestational Diabetes in High Risk Pregnant Women

NCT03037593 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2019-11-01

No results posted yet for this study

Summary

Demonstrate dose-dependent relationship between vitamin D supplementation and rates of gestational diabetes.

Conditions

  • Gestational Diabetes

Interventions

DRUG

4000 IU vitamin D3

vitamin D supplementation (4000 IU vitamin D3 +prenatal vitamin

Sponsors & Collaborators

Principal Investigators

  • Samantha Hoffman, MD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2020-06-30
Completion
2020-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03037593 on ClinicalTrials.gov